Wilson Sonsini Goodrich & Rosati has advised SonoThera. SonoThera has announced the successful closing of an oversubscribed $125 million Series B financing round. The proceeds from...
SonoThera Secures $125 Million in Oversubscribed Series B Financing
Galvanize Therapeutics Secures $100 Million in Series C Financing
Wilson Sonsini Goodrich & Rosati has advised Galvanize Therapeutics, Inc. Galvanize Therapeutics, Inc., a commercial-stage medical technology company focused on pioneering pulsed electric field (PEF) therapies...
Matterworks Secures Series A Financing
Wilson Sonsini Goodrich & Rosati has advised Matterworks on IP and patent matters on the transaction Matterworks, Inc., a leader in predictive biology through the utilization...
Magenta Medical’s $105 Million Financing Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Magenta Medical (Magenta) announced that it has raised $105 million in financing. The financing was...
Novo Holdings’ Acquisition of Majority Stake in Single Use Support
DORDA, Kromann Reumert and Linklaters advised Novo Holdings A/S on the transaction. Wilson Sonsini Goodrich & Rosati advised Novo Holdings on IP Matters. Novo Holdings A/S...
L Catterton’s $680 Million Acquisition of Thorne HealthTech
Kirkland & Ellis LLP is representing L Catterton, and Wilson Sonsini Goodrich & Rosati is representing Thorne HealthTech, Inc. in the transaction. Thorne HealthTech, Inc. (“Thorne”)...
Roche’s Acquisition of Good Therapeutics
Wilson Sonsini advised Good Therapeutics on the deal. Good Therapeutics, a privately held company founded to create a new class of conditionally active therapeutics, announced it...